Board approves $15 million for continuation of strategic investments in community, rights and gender over 2017-2019
The Global Fund will invest $15 million over the next three years (2017-2019) to bolster community responses, human rights and gender equality in its grants.
Advocacy for increased domestic funding led by CSOs and PRs, and strongly underpinned by the Global Fund’s conditions put to the government of Ukraine, has achieved outstanding results. Communities, empowered by the Global Fund, have been able to partner with the Ministry of Health.
AHF and researchers call for more transparency in UNAIDS’ estimates of the numbers of people on ARVs
The AIDS Healthcare Foundation (AHF), a Los Angeles-based AIDS service and activist organization with a global reach, has called for more transparency and accountability in the way UNAIDS estimates the number of people living with HIV/AIDS who are on life-saving antiretroviral treatment.
As part of its new strategy for 2017-2022, the Global Fund has placed increased emphasis on rights and gender. One of the four strategic objectives focuses directly on promoting and protecting human rights and gender equality, aiming to scale up programs to support women and girls (including programs to advance sexual and reproductive health and rights) and invest to reduce health inequities (including gender and age-related disparities).
Additional information on the decision not to approve extensions for HIV and TB grants to Bosnia and Hercegovina
In GFO #293, we reported that the Global Fund Board turned down a recommendation to provide additional funding for a TB grant and an HIV grant in Bosnia and Herzegovina. Although to still do now know why the Board decided not to grant the additional funding, we now have additional information on what was being requested and why. As well, we are able to report on the reaction of the principal recipient (PR), UNDP.
On 3 August 2016, the Board approved additional funding of $37 million to ensure that all essential services for a shortened HIV grant to Uganda can be provided through to 31 December 2017. The money will come from the $700 million which the Fund has identified as being available for portfolio optimization. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).
As reported in GFO #293, the Board has awarded Tanzania’s shortened HIV grant an extension of $109 million to allow it to continue providing essential HIV services through to the end of 2017. The original grant, totaling $277.5 million had an end date of 31 December 2016.
GFO has learned that the Global Fund Board has turned down a recommendation to provide additional funding for a TB grant and an HIV grant in Bosnia and Herzegovina.
There has been no public announcement of the Board decision. Nor has the Global Fund made public any details concerning the amounts involved, the rationale for the recommendation, or the reasons why the recommendation was not approved.
The Global Fund’s replenishment campaign received a critical advocacy boost in Durban at the 21st International Congress on AIDS with several high-profile side events and the release of the Global Fund Advocates Network’s (GFAN) Cost of Inaction 2016 Report (see GFO article in this issue).